A detailed history of Raymond James & Associates transactions in Masimo Corp stock. As of the latest transaction made, Raymond James & Associates holds 175,050 shares of MASI stock, worth $29.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
175,050
Previous 180,533 3.04%
Holding current value
$29.5 Million
Previous $22.7 Million 2.61%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$104.79 - $133.77 $574,563 - $733,460
-5,483 Reduced 3.04%
175,050 $23.3 Million
Q2 2024

Jul 19, 2024

SELL
$115.24 - $144.91 $124,228 - $156,212
-1,078 Reduced 0.59%
180,533 $22.7 Million
Q1 2024

Apr 22, 2024

BUY
$109.17 - $146.85 $217,903 - $293,112
1,996 Added 1.11%
181,611 $26.7 Million
Q4 2023

Jan 16, 2024

SELL
$76.73 - $120.62 $1.69 Million - $2.66 Million
-22,037 Reduced 10.93%
179,615 $21.1 Million
Q3 2023

Oct 24, 2023

SELL
$84.17 - $161.17 $5.37 Million - $10.3 Million
-63,840 Reduced 24.05%
201,652 $17.7 Million
Q2 2023

Jul 25, 2023

SELL
$155.24 - $196.47 $917,157 - $1.16 Million
-5,908 Reduced 2.18%
265,492 $43.7 Million
Q1 2023

Apr 14, 2023

BUY
$146.03 - $184.54 $1.41 Million - $1.78 Million
9,655 Added 3.69%
271,400 $50.1 Million
Q4 2022

Feb 08, 2023

SELL
$110.88 - $150.36 $2.36 Million - $3.2 Million
-21,283 Reduced 7.52%
261,745 $38.7 Million
Q3 2022

Oct 25, 2022

SELL
$125.58 - $169.38 $75,599 - $101,966
-602 Reduced 0.21%
283,028 $40 Million
Q2 2022

Aug 12, 2022

SELL
$112.97 - $151.71 $187,530 - $251,838
-1,660 Reduced 0.58%
283,630 $37.1 Million
Q1 2022

May 11, 2022

BUY
$135.71 - $284.87 $61,476 - $129,046
453 Added 0.16%
285,290 $41.5 Million
Q4 2021

Feb 08, 2022

SELL
$266.41 - $303.29 $4.87 Million - $5.55 Million
-18,293 Reduced 6.03%
284,837 $83.4 Million
Q3 2021

Nov 02, 2021

SELL
$249.0 - $285.24 $223,353 - $255,860
-897 Reduced 0.3%
303,130 $82.1 Million
Q2 2021

Aug 11, 2021

SELL
$208.49 - $248.2 $904,638 - $1.08 Million
-4,339 Reduced 1.41%
304,027 $73.7 Million
Q1 2021

May 14, 2021

BUY
$220.31 - $283.75 $710,720 - $915,377
3,226 Added 1.06%
308,366 $70.8 Million
Q4 2020

Feb 12, 2021

SELL
$223.82 - $271.35 $603,642 - $731,830
-2,697 Reduced 0.88%
305,140 $81.9 Million
Q3 2020

Nov 04, 2020

BUY
$209.49 - $246.81 $291,400 - $343,312
1,391 Added 0.45%
307,837 $72.7 Million
Q2 2020

Jul 28, 2020

BUY
$178.49 - $250.39 $824,266 - $1.16 Million
4,618 Added 1.53%
306,446 $69.9 Million
Q1 2020

Apr 21, 2020

SELL
$148.38 - $186.78 $619,931 - $780,366
-4,178 Reduced 1.37%
301,828 $53.5 Million
Q4 2019

Feb 12, 2020

BUY
$140.81 - $159.49 $183,334 - $207,655
1,302 Added 0.43%
306,006 $48.4 Million
Q3 2019

Nov 07, 2019

BUY
$145.61 - $159.87 $123,331 - $135,409
847 Added 0.28%
304,704 $45.3 Million
Q2 2019

Aug 06, 2019

SELL
$122.29 - $148.82 $7,215 - $8,780
-59 Reduced 0.02%
303,857 $45.2 Million
Q1 2019

May 06, 2019

SELL
$102.78 - $138.28 $3.01 Million - $4.05 Million
-29,267 Reduced 8.78%
303,916 $42 Million
Q4 2018

Feb 11, 2019

BUY
$98.38 - $125.32 $1.02 Million - $1.3 Million
10,378 Added 3.21%
333,183 $35.8 Million
Q3 2018

Nov 14, 2018

SELL
$97.19 - $124.54 $155,795 - $199,637
-1,603 Reduced 0.49%
322,805 $40.2 Million
Q2 2018

Aug 14, 2018

SELL
$83.88 - $102.21 $138,150 - $168,339
-1,647 Reduced 0.51%
324,408 $31.7 Million
Q1 2018

May 14, 2018

SELL
$82.06 - $95.19 $2.01 Million - $2.33 Million
-24,448 Reduced 6.98%
326,055 $28.7 Million
Q4 2017

Feb 14, 2018

SELL
$84.49 - $90.09 $184,441 - $196,666
-2,183 Reduced 0.62%
350,503 $29.7 Million
Q3 2017

Nov 13, 2017

BUY
$81.79 - $96.62 $71,484 - $84,445
874 Added 0.25%
352,686 $30.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
351,812
351,812 $32.1 Million

Others Institutions Holding MASI

About MASIMO CORP


  • Ticker MASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 52,530,200
  • Market Cap $8.84B
  • Description
  • Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...
More about MASI
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.